Obamacare Is Causing Insurers To Delay Surgeries Patients Need
Republicans can begin to fix this problem. Reform can be pro-market without being pro-business. That is, policy improvements can be pro-patient without fueling the insurance oligopoly.
The actual pre-authorization process is cumbersome. After a surgeon and his or her patient decide on a treatment plan, the insurance company must pre-approve the treatment or it won’t pay for it. If the insurance company won’t pay for the procedure, the patient likely won’t have surgery.
The very involvement of an insurance company in the actual health-care decisions of a patient and doctor should cause great pause. The most vital element of our entire health-care apparatus is the patient-physician relationship. To the surgeon, it’s sacrosanct. Insurance companies are trying to disrupt this for financial benefit.
The concept might be mildly tolerated if the pre-authorization process were grounded in patient related data and outcomes. It is largely not. It’s a fiscal instrument.
Republicans can begin to fix this problem. Reform can be pro-market without being pro-business. That is, policy improvements can be pro-patient without fueling the insurance oligopoly.
The actual pre-authorization process is cumbersome. After a surgeon and his or her patient decide on a treatment plan, the insurance company must pre-approve the treatment or it won’t pay for it. If the insurance company won’t pay for the procedure, the patient likely won’t have surgery.
The very involvement of an insurance company in the actual health-care decisions of a patient and doctor should cause great pause. The most vital element of our entire health-care apparatus is the patient-physician relationship. To the surgeon, it’s sacrosanct. Insurance companies are trying to disrupt this for financial benefit.
The concept might be mildly tolerated if the pre-authorization process were grounded in patient related data and outcomes. It is largely not. It’s a fiscal instrument.